Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Aaron Joseph Whiting, M.D.
Family Practice · BOONVILLE, MO · NPI 1225359573
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 650 | 170 |
| Omeprazole | Omeprazole | 537 | 130 |
| Levothyroxine Sodium | Levothyroxine Sodium | 509 | 127 |
| Losartan Potassium | Losartan Potassium | 506 | 121 |
| Lisinopril | Lisinopril | 498 | 132 |
| Amlodipine Besylate | Amlodipine Besylate | 496 | 117 |
| Hydrochlorothiazide | Hydrochlorothiazide | 449 | 112 |
| Metformin Hcl | Metformin Hcl | 382 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 279 | 61 |
| Furosemide | Furosemide | 243 | 64 |
| Citalopram Hbr | Citalopram Hydrobromide | 237 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 233 | 53 |
| Gabapentin | Gabapentin | 216 | 52 |
| Simvastatin | Simvastatin | 187 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 187 | 53 |
| Sertraline Hcl | Sertraline Hcl | 182 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 171 | 63 |
| Eliquis | Apixaban | 159 | 33 |
| Tramadol Hcl | Tramadol Hcl | 147 | 46 |
| Pravastatin Sodium | Pravastatin Sodium | 146 | 35 |
| Trazodone Hcl | Trazodone Hcl | 146 | 33 |
| Potassium Chloride | Potassium Chloride | 144 | 37 |
| Allopurinol | Allopurinol | 142 | 34 |
| Metformin Hcl Er | Metformin Hcl | 129 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 113 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 108 | 27 |
| Carvedilol | Carvedilol | 107 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 105 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 25 |
| Finasteride | Finasteride | 99 | 27 |
| Montelukast Sodium | Montelukast Sodium | 96 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 95 | 16 |
| Glimepiride | Glimepiride | 81 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 80 | 19 |
| Jardiance | Empagliflozin | 80 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 18 |
| Atenolol | Atenolol | 73 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 71 | 16 |
| Donepezil Hcl | Donepezil Hcl | 70 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 70 | 17 |
| Alprazolam | Alprazolam | 69 | 12 |
| Lovastatin | Lovastatin | 67 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 67 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 18 |
| Mirtazapine | Mirtazapine | 64 | suppressed |
| Meloxicam | Meloxicam | 61 | 19 |
| Celecoxib | Celecoxib | 56 | 14 |
| Prednisone | Prednisone | 54 | 39 |
| Alendronate Sodium | Alendronate Sodium | 53 | 14 |
| Memantine Hcl | Memantine Hcl | 53 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 47 | suppressed |
| Spironolactone | Spironolactone | 46 | 16 |
| Clonazepam | Clonazepam | 45 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 40 | suppressed |
| Ezetimibe | Ezetimibe | 40 | 11 |
| Famotidine | Famotidine | 40 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | suppressed |
| Xarelto | Rivaroxaban | 39 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | 11 |
| Warfarin Sodium | Warfarin Sodium | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Synthroid | Levothyroxine Sodium | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 32 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 32 | suppressed |
| Ozempic | Semaglutide | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Pregabalin | Pregabalin | 32 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Trimethoprim | Trimethoprim | 30 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 29 | 29 |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Lorazepam | Lorazepam | 27 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Estradiol | Estradiol | 17 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 14 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 12 |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Cimetidine | Cimetidine | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Bicalutamide | Bicalutamide | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error